The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...

When it comes to losing fat without extreme exercise, only a few medicines are worth considering. With the innovation in the medical world, physicians are now recommending the Ozempic weight loss ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

No, it’s not ‘brat’, ‘demure’, or even ‘brain rot’; it’s Ozempic. The drug has become increasingly popular for helping people (including your favourite celebrities) lose weight ...

Novo Nordisk’s (NVO) weight-loss drug, which shares an active ingredient with Ozempic ... pen that the drug typically comes in, at a cheaper price. A four-week supply of the 2.5 mg Zepbound ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food and drink makers to cash in. Consumers taking GLP-1 drugs to lose weight ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

That medical appointment was in spring 2023, and the doctor explained that Ozempic, a drug for diabetic ... At 37, I knew it was time to take action. The pen injections cost $900 a month,* but ...